Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Long-term damage assessment in patients with microscopic polyangiitis and renal-limited vasculitis using the Vasculitis Damage Index.

Itabashi M, Takei T, Moriyama T, Shiohira S, Shimizu A, Tsuruta Y, Uchida K, Nitta K.

Mod Rheumatol. 2014 Jan;24(1):112-9. doi: 10.3109/14397595.2013.852836.

PMID:
24261767
2.

Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials.

Robson J, Doll H, Suppiah R, Flossmann O, Harper L, Höglund P, Jayne D, Mahr A, Westman K, Luqmani R.

Ann Rheum Dis. 2015 Jan;74(1):177-84. doi: 10.1136/annrheumdis-2013-203927. Epub 2013 Nov 15.

PMID:
24243925
3.

Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index.

Suppiah R, Flossman O, Mukhtyar C, Alberici F, Baslund B, Brown D, Hasan N, Holle J, Hruskova Z, Jayne D, Judge A, Little MA, Merkel PA, Palmisano A, Seo P, Stegeman C, Tesar V, Vaglio A, Westman K, Luqmani R.

Ann Rheum Dis. 2011 Jan;70(1):80-5. doi: 10.1136/ard.2009.122952. Epub 2010 Aug 24.

4.

Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials.

Robson J, Doll H, Suppiah R, Flossmann O, Harper L, Höglund P, Jayne D, Mahr A, Westman K, Luqmani R.

Rheumatology (Oxford). 2015 Mar;54(3):471-81. doi: 10.1093/rheumatology/keu366. Epub 2014 Sep 8.

PMID:
25205825
5.

Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides.

Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage CO, Adu D.

Arthritis Rheum. 1997 Feb;40(2):371-80.

6.

Activity and damage in granulomatosis with polyangiitis.

Yegin EG, Can M, Yilmaz N, Aydin SZ, Yavuz S, Tuglular S, Direskeneli H.

Int J Rheum Dis. 2013 Feb;16(1):61-71. doi: 10.1111/1756-185x.12022. Epub 2013 Feb 2.

PMID:
23441774
7.

The extent and pattern of organ damage in small vessel vasculitis measured by the Vasculitis Damage Index (VDI).

Mohammad AJ, Bakoush O, Sturfelt G, Segelmark M.

Scand J Rheumatol. 2009;38(4):268-75. doi: 10.1080/03009740802668554.

PMID:
19296401
8.

Lung involvement at presentation predicts disease activity and permanent organ damage at 6, 12 and 24 months follow - up in ANCA - associated vasculitis.

Hassan TM, Hassan AS, Igoe A, Logan M, Gunaratnam C, McElvaney NG, O'Neill SJ.

BMC Immunol. 2014 May 27;15:20. doi: 10.1186/1471-2172-15-20.

9.

Outcome analysis of patients with vasculitis associated with antineutrophil cytoplasmic antibodies.

Brijker F, Magee CC, Tervaert JW, O'Neill S, Walshe JJ.

Clin Nephrol. 1999 Dec;52(6):344-51.

PMID:
10604641
10.

Risk factors associated with relapse or infectious complications in Japanese patients with microscopic polyangiitis.

Kitagawa K, Furuichi K, Sagara A, Shinozaki Y, Kitajima S, Toyama T, Hara A, Iwata Y, Sakai N, Shimizu M, Kaneko S, Wada T; Kanazawa Study Group for Renal Diseases and Hypertension..

Clin Exp Nephrol. 2016 Oct;20(5):703-711. Epub 2015 Nov 20.

PMID:
26590051
11.

ANCA-associated vasculitis in Hispanic Americans: an unrecognized severity.

Sreih AG, Mandhadi R, Aldaghlawi F, Khan A, Irshad V, Finn K, Block JA.

Clin Rheumatol. 2015 May;34(5):943-8. doi: 10.1007/s10067-014-2617-z. Epub 2014 Apr 22.

PMID:
24752347
12.

Predictors of damage and survival in patients with Wegener's granulomatosis: analysis of 50 patients.

Kamali S, Erer B, Artim-Esen B, Gul A, Ocal L, Konice M, Aral O, Inanc M.

J Rheumatol. 2010 Feb;37(2):374-8. doi: 10.3899/jrheum.090387. Epub 2009 Dec 15. Erratum in: J Rheumatol. 2010 Jul;37(7):1551.

PMID:
20008921
13.

Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).

Seo P, Min YI, Holbrook JT, Hoffman GS, Merkel PA, Spiera R, Davis JC, Ytterberg SR, St Clair EW, McCune WJ, Specks U, Allen NB, Luqmani RA, Stone JH; WGET Research Group..

Arthritis Rheum. 2005 Jul;52(7):2168-78.

14.

Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study.

Sada KE, Yamamura M, Harigai M, Fujii T, Takasaki Y, Amano K, Fujimoto S, Muso E, Murakawa Y, Arimura Y, Makino H; Research Committee on Intractable Vasculitides, the Ministry of Health, Labour and Welfare of Japan..

Arthritis Res Ther. 2015 Nov 2;17:305. doi: 10.1186/s13075-015-0815-y.

15.

A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis.

Suppiah R, Mukhtyar C, Flossmann O, Alberici F, Baslund B, Batra R, Brown D, Holle J, Hruskova Z, Jayne DR, Judge A, Little MA, Palmisano A, Stegeman C, Tesar V, Vaglio A, Westman K, Luqmani R.

Rheumatology (Oxford). 2011 May;50(5):899-905. doi: 10.1093/rheumatology/keq400. Epub 2010 Dec 13.

PMID:
21156667
16.

Clinical and Economic Burden of Antineutrophil Cytoplasmic Antibody-associated Vasculitis in the United States.

Raimundo K, Farr AM, Kim G, Duna G.

J Rheumatol. 2015 Dec;42(12):2383-91. doi: 10.3899/jrheum.150479. Epub 2015 Nov 1.

17.

Primary systemic vasculitis: clinical features and mortality.

Lane SE, Watts RA, Shepstone L, Scott DG.

QJM. 2005 Feb;98(2):97-111. Epub 2005 Jan 17.

PMID:
15655098
18.

Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.

Hruskova Z, Stel VS, Jayne D, Aasarød K, De Meester J, Ekstrand A, Eller K, Heaf JG, Hoitsma A, Martos Jimenéz C, Ravani P, Wanner C, Tesar V, Jager KJ.

Am J Kidney Dis. 2015 Oct;66(4):613-20. doi: 10.1053/j.ajkd.2015.03.025. Epub 2015 May 12.

PMID:
25975963
19.

Long-term damage to the ENT system in Wegener's granulomatosis.

Martinez Del Pero M, Walsh M, Luqmani R, Flossmann O, Mukhtyar C, Jani P, Rasmussen N, Jayne D.

Eur Arch Otorhinolaryngol. 2011 May;268(5):733-9. doi: 10.1007/s00405-010-1421-x. Epub 2010 Nov 18.

PMID:
21085976
20.

Outcome and treatment of elderly patients with ANCA-associated vasculitis.

Weiner M, Goh SM, Mohammad AJ, Hruskova Z, Tanna A, Bruchfeld A, Selga D, Chocova Z, Westman K, Eriksson P, Pusey CD, Tesar V, Salama AD, Segelmark M.

Clin J Am Soc Nephrol. 2015 Jul 7;10(7):1128-35. doi: 10.2215/CJN.00480115. Epub 2015 Jun 22.

Supplemental Content

Support Center